Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Story being shared
Foundation partners with Array on cancer drug responses
Foundation Medicine has signed a deal to use its genome sequencing technology to help pinpoint patients who may potentially respond to cancer drugs developed by Array BioPharma. The company has similar agreements with pharmaceutical firms Johnson & Johnson, Novartis, Sanofi and Celgene.
Or we can send an email on your behalf